REAL-WORLD DATA – THE GOOD, THE BAD, AND THE UGLY
This webpage contains promotional information about ViiV Healthcare products. Information provided within this page has been approved to UK regulations and may be subject to different medical and regulatory requirements in other countries. It is important to follow local laws and regulations when prescribing medicines.
Links to GB and NI prescribing information can be found on this page.
Watch this educational event on demand. An expert faculty explore the generation and use of real-world data, particularly focusing on:
- Evaluating the quality of real-world evidence
- Setting up effective real-world studies
- Examples of current real-world data that showcase use in clinical practice
WATCH ON DEMAND
SPEAKERS
Prof. Caroline Sabin
University College London, London, UK
Caroline Sabin, PhD, is a Professor of Medical Statistics and Epidemiology at University College London (UCL), the Director of the NIHR Health Protection Research Unit in Blood-Borne and Sexually Transmitted Infections at UCL and the current vice-chair of BHIVA. Caroline’s interests lie in describing the natural history of HIV infection, identifying prognostic markers and describing responses and adverse events to combination ART (cART). She established the UK Collaborative HIV Cohort (UK CHIC) Study, was the principal statistician for the D:A:D Study and is the co-primary investigator for the POPPY study.
Dr Dominique Braun
University Hospital Zurich, Zurich, Switzerland
Dominique Braun is a senior staff physician working at the Division of Infectious Diseases and Hospital Epidemiology in the University Hospital Zurich. Dominique’s research areas cover HIV, hepatitis C, sexually transmitted infections, HIV pre-exposure prophylaxis and, for obvious reasons during the last 2 years, also COVID-19. Dominique completed a board certificate in Internal Medicine, Infectious Diseases and recently in Pharmaceutical Medicine. Dominique participates in numerous clinical trials, in particular HIV trials investigating new therapeutic treatment options.
Assist. Prof. Juan Ambrosioni
Hospital Clinic-IDIBAPS and University of Barcelona, Barcelona, Spain
Juan Ambrosioni MD, PhD, is a specialist in the HIV/AIDS Unit and Infectious Disease Service, as well as an Assistant Professor of Medicine, at the University of Barcelona. He is also an Infectious Diseases specialist at the University of Buenos Aires, Argentina and the University of Geneva, Switzerland. Juan has co-authored over 150 peer-reviewed scientific articles (he is the first, last or corresponding author on more than 40 of these) and more than 30 book chapters. He is the principal investigator for national and international projects in the field of HIV infection, HIV co-infections and opportunistic infections. He is also a coordinator of the European AIDS Clinical Society (EACS) Guidelines.
GET IN TOUCH
Want to ask a medical information question?
Contact your local Medical Science Liaison
For UK residents:
Adverse events should be reported. For the UK reporting forms and information can be found at https://yellowcard.mhra.gov.uk.
Adverse events should also be reported to ViiV/GSK at uksafety@gsk.com or call 0800 221441
Outside the UK?
For more information on how to report an adverse event, please use this online tool. This facility is provided by GSK, so you will be redirected to a GSK webpage.
PM-GBL-HVX-WCNT-220012 October 2022
Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221441.
If you are from outside the UK, you can report adverse events to GSK/ViiV by selecting your region and market, here.
